Abundance Wealth Counselors
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1767080
STATE COLLEGE, PA
Position in VRTX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$901,564
+$493,873 QoQ
Shares Held
1,815
+98.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#884
of 1,735 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Abundance Wealth Counselors holds $2,464,923 across 7 Biotechnology names. VRTX ranks #1 (36.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,815 | $901,564 | |
| 2 | INCY |
Incyte Corp
|
3,304 | $374,541 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,806 | $315,904 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
488 | $304,287 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
5,015 | $273,518 | |
| 6 | MRNA |
Moderna, Inc.
|
2,950 | $206,588 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
10,111 | $88,521 |
All Filings in VRTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $901,564 | 1,815 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $407,691 | 913 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $300,577 | 663 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $259,265 | 662 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $332,119 | 746 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $313,193 | 646 | Shares | Sole | 2025-04-21 | |
| 2024-06-30 | $201,080 | 429 | Shares | Sole | 2024-07-17 | |
| No filing history on record for this holder in this stock. | ||||||